Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 36, 2002 - Issue 5
Submit an article Journal homepage
42
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Low Response to HBsAg Vaccine in Chronic Renal Failure Patients is not due to Intrinsic Defect of B Cells

G. Krishnamurthy Uniformed Services University, Washington, USA
,
Vijay Kher Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Currently Consultant Nephrologist, Indraprastha Apollo, New Delhi, India
&
Sita Naik Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Pages 377-382 | Published online: 09 Jul 2009

  • Kher V, Bhawmick SK. Tuberculosis in renal failure - Role of Vitamin D3. Ind J Nephrol 1992; 2: 29-31.
  • Chia S, Karim M, Elwood RK, FitzGerald JM. Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis 1998; 2: 989-91.
  • Jha R, Kher V, Naik S, Elhence R, Gupta A, Sharma RK. Hepatitis B associated liver disease in dialysis patients: Role of vaccination. J Nephrol 1993; 6: 98.
  • Petrosillo N, Puro V, Ippolito G. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among dialysis patients: The Italian multi centric study on nosocomial and occupational risk of blood-borne infections in dialysis. Nephron 1993; 64: 636.
  • Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997; 12: S236-41.
  • Chetanoud L, Herbelin A, Beauran G, Descamps Latscha B. Immune deficiency of the uremie patient. Adv Nephrol 1990; 19: 259-74.
  • Krishnamurthy G, Kher V, Naik Sita. Defective lymphoproliferative response and interleukin-2 production in chronic renal failure patients. Indian J Med Res 1995; 102: 281-6.
  • Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 1996; 16: 192-201.
  • Koziol-Montewka M, Ksiazek A, Majdan M, Spasiewicz D, Brydak L, Janicka L, et al. Influence of some immune factors on the IL-6 and soluble IL-2 receptors in hemodialysis patients. Int J Urol Nephrol 1997; 29: 369-75.
  • Borradori L, Born B, Descoeudres C, Skvaril F, Moreli A. Serum immunoglobulin levels and natural antibodies to Haemophilus influenzae in hemodialysis patients: evidence for IgG subclass imbalance. Nephron 1990; 56: 35-9.
  • Kruger S, Seyfarth M, Sack K, Kreft B. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Vaccine 1999; 17: 1145-50.
  • Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22: 434-46.
  • Degiannis D, Mowat AMCI, Galloway E, Tsakiris D, Briggs JD, Junor BJR, et al. In vitro analysis of B lymphocyte function in uremia. Clin Exp Immunol 1987; 70: 463-70.
  • Rasakova J, Ghobrial I, Czerwinski DK, Shea ST, Eisinger RP, Raska K. B cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987; 147: 89-93.
  • Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic hemodialysis adult patients: A multicentre prospective survey. Nephrol Dial Transplant 1995; 10: 377-81.
  • Ifudu O, Brezsynyak WF, Reydel C, McClendon E, Surgrue T, DiRienzo R, et al. Pathobiology and functional status of long-term dialysis patients. Am J Nephrol 1995; 15: 379-85.
  • Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, et al. Balance between IL-Iß, TNF-a and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995; 154: 882-92.
  • Bird AG, Britton S, Ernberg I, Nilsson K. Characteristics of Epstein Barr virus activation of human B lymphocytes. J Exp Med 1981; 154: 832-8.
  • Gaciong Z, Alexiewicz JM, Linker-Israeli M, Shulman IA, Pitts TO, Massry SG. Inhibition of immunoglobulin production by parathyroid hormone. Implications for chronic renal failure. Kidney Int 1991; 40: 96-106.
  • Caillat-Zucman S, Giminez JJ, Albouze G, Lebkiri B, Naret C, Jungers P, et al. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialysis patients. Kidney Int Suppl 1993; 43: S157-60.
  • Stachowski J, Poollock M, Barth C, Maciejewski J, Baldamus CA. Non-responsiveness to hepatitis B vaccination in hemodialysis patients: Association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition. Nephrol Dial Transplant 1994; 9: 144-52.
  • Daichou Y, Kurashige S, Hashimoto S, Suzuki S. Characteristic cytokine products of TH1 and TH2 cells in hemodialysis patients. Nephron 1999; 83: 237-45.
  • Krishnamurthy G, Kher V, Naik S. Immunogenicity and efficacy of hepatitis B vaccination in Indian chronic renal failure patients on hemodialysis and after renal transplantation. Nephron 1996; 74: 424-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.